AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule ...

AN2 Therapeutics said it was planning to meet with the U.S. Food and Drug Administration to discuss a development path for epetraborole, a treatment of non-tuberculous mycobacterial lung disease. The ...

AN2 Therapeutics, Inc. ( (ANTX)) has shared an announcement. AN2 Therapeutics has promoted its Chief Legal Counsel, Joshua Eizen, to the roles of Chief Legal Officer and Chief Operating Officer, ...

MENLO PARK, Calif. - AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company specializing in boron-based small molecule therapeutics, has announced the extension of a research grant from ...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...

Chesapeake Gold Corp. TSX-Venture Symbol: CKG All Issues: Yes Reason: Pending News Halt Time (ET): 3:39 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in ...

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its ...

MENLO PARK, Calif. - AN2 Therapeutics, Inc. (NASDAQ:ANTX), a biopharmaceutical company specializing in boron-based small molecule therapeutics, has announced the extension of a research grant from the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – ...

If ultimately fully funded, the MPC2SC Program will start by identifying 10 students at the community college during their ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...